Approved programs must meet specific parameters established by CMS, including that they are population or public health focused and serve a community largely made up of low-income individuals, and the state must show that the freed up state funding is used for another demonstration initiative that will promote the objectives of the Medicaid program
We will do this by adjusting your dosing every month to achieve that goal if tolerated
Cagrilintide is not for human or animal consumption , not for therapeutic use, and is not intended to diagnose, treat, cure, or prevent any disease or condition
Most side effects are minimal and mild
Chemical Structure GLP1Component 2D molecular structure of GLP1 component (Source: PubChem) Chemical Structure Cagrilintide Component 2D molecular structure of cagrilintide component (Source: PubChem) Technical Specifications GLP1 Component: Cagrilintide Component: The combination formulation provides each peptide at 2.4 mg per dose in a fixed-ratio, once-weekly subcutaneous injection